Your browser is no longer supported. Please, upgrade your browser.
ClearPoint Neuro, Inc.
Index- P/E- EPS (ttm)-0.44 Insider Own2.80% Shs Outstand15.72M Perf Week41.62%
Market Cap339.04M Forward P/E- EPS next Y-0.53 Insider Trans0.00% Shs Float12.02M Perf Month61.74%
Income-6.80M PEG- EPS next Q-0.14 Inst Own6.20% Short Float2.00% Perf Quarter212.61%
Sales12.30M P/S27.56 EPS this Y25.30% Inst Trans0.11% Short Ratio1.20 Perf Half Y378.97%
Book/sh0.01 P/B2232.00 EPS next Y-10.40% ROA-34.10% Target Price18.00 Perf Year330.89%
Cash/sh0.97 P/C23.06 EPS next 5Y30.00% ROE-309.90% 52W Range2.86 - 20.56 Perf YTD40.47%
Dividend- P/FCF- EPS past 5Y32.70% ROI-68.60% 52W High8.56% Beta1.21
Dividend %- Quick Ratio4.50 Sales past 5Y25.50% Gross Margin74.00% 52W Low680.39% ATR1.69
Employees33 Current Ratio5.40 Sales Q/Q20.70% Oper. Margin-43.80% RSI (14)84.50 Volatility14.51% 9.76%
OptionableNo Debt/Eq178.00 EPS Q/Q-18.10% Profit Margin-55.60% Rel Volume2.76 Prev Close19.39
ShortableYes LT Debt/Eq177.00 Earnings- Payout- Avg Volume199.90K Price22.32
Recom2.00 SMA2040.03% SMA5081.36% SMA200245.24% Volume552,607 Change15.11%
Jul-17-20Initiated B. Riley FBR Buy $8
Jan-22-21 04:30PM  
Jan-14-21 04:05PM  
Jan-12-21 04:05PM  
Dec-29-20 04:15PM  
Dec-28-20 12:13AM  
Dec-02-20 10:18AM  
Nov-30-20 09:15AM  
Nov-27-20 06:00AM  
Nov-17-20 03:52PM  
Nov-14-20 03:53PM  
Nov-13-20 05:41AM  
Nov-12-20 12:25PM  
Nov-10-20 04:05PM  
Nov-09-20 03:09PM  
Nov-04-20 04:05PM  
Oct-24-20 06:24PM  
Sep-14-20 04:15PM  
Aug-12-20 04:05PM  
Aug-06-20 08:00AM  
Jul-17-20 09:25AM  
May-12-20 04:05PM  
May-07-20 04:05PM  
Apr-17-20 08:10AM  
Apr-16-20 08:00AM  
Feb-14-20 08:55AM  
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The company has a license agreements with The Johns Hopkins University; development agreement with Mayo Clinic to design and develop MRI-guided therapies for stroke; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was founded in 1998 and is headquartered in Irvine, California.